Abstract: Pyrrole pyrazole compounds of formula I, compositions including these compounds and methods of their use are provided. Preferred compounds of formula I have activity as protein kinase inhibitors, including as inhibitors of PAK4.
Type:
Grant
Filed:
December 28, 2005
Date of Patent:
November 29, 2011
Assignees:
Agouron Pharmaceuticals, Inc., Pfizer Inc.
Inventors:
Junhu Zhang, Chuangxing Guo, Djamal Bouzida, Liming Dong, Haitao Li, Joseph Timothy Marakovits, Anle Yang, Yufeng Hong